According to a new report from Intel Market Research, the global Calcitriol market was valued at USD 347 million in 2025 and is projected to reach USD 438 million by 2034, growing at a steady CAGR of 3.5% during the forecast period (2025–2034). This growth is driven by the rising prevalence of chronic kidney disease, expanding therapeutic applications in bone and skin disorders, and...

According to a new report from Intel Market Research, the global Digital Therapeutics Devices market was valued at USD 6.51 billion in 2025 and is projected to grow from USD 7.82 billion in 2026 to USD 35.78 billion by 2034, exhibiting a robust CAGR of 21.0% during the forecast period (2026–2034). This rapid expansion is underpinned by escalating prevalence of chronic illnesses, soaring...

According to a new report from Intel Market Research, the global Intelligent Infusion Management System market was valued at USD 1024 million in 2025 and is projected to reach USD 1701 million by 2034, growing at a robust CAGR of 7.7% during the forecast period (2025–2034). This growth is propelled by surging demand from aging populations and chronic diseases, strong policy support such...

Respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), and other chronic lung conditions, require ongoing attention and careful monitoring. Effective Disease management at home empowers patients to control symptoms, prevent flare-ups, and maintain optimal lung function. With the support of services like Doctor at Home, individuals can receive expert guidance,...

The United States represents a significant market for deferasirox, driven by the growing prevalence of transfusion-dependent blood disorders such as thalassemia, sickle cell disease, and myelodysplastic syndromes. The country benefits from a well-established healthcare infrastructure, advanced diagnostic capabilities, and strong access to specialized hematology treatments. Increasing awareness...